| [1] |
Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang.
Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3
[J]. Clinical Focus, 2024, 39(2): 121-124.
|
| [2] |
Zhang Canna, Xiang Lu, Luo Yaxiong.
Electrocardiographic findings of the spiked helmet sign: A case report and literature review
[J]. Clinical Focus, 2023, 38(5): 444-447.
|
| [3] |
Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian.
Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation
[J]. Clinical Focus, 2023, 38(4): 308-314.
|
| [4] |
Zhou Huixian, Zhou Yaqing, Guo Ganlin, Cui Wei.
Therapy on left ventricular thrombus:Systematic review and meta-analysis
[J]. Clinical Focus, 2023, 38(2): 101-110.
|
| [5] |
Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong.
Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score
[J]. Clinical Focus, 2023, 38(2): 117-120.
|
| [6] |
Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi.
Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis
[J]. Clinical Focus, 2022, 37(9): 773-778.
|
| [7] |
Zhang Haifu, Ye Xiangqing, Chen Zhexu, Chen Shijian, Yang Dong, Zhang Xingwei.
Effects of moderate exercise on the prognosis of patients with atrial fibrillation:A systematic review and Meta-analysis
[J]. Clinical Focus, 2022, 37(6): 485-489.
|
| [8] |
Zhang Jingshui, Xu Yanan, Wang Jun, Yang Yi, Jiang Haibing, Tang Long, Wang Xianping, Shao Mingliang.
Clinical characteristics and long-term prognosis of initial patients with new onset different type of heart failure combined atrial fibrillation
[J]. Clinical Focus, 2022, 37(6): 504-509.
|
| [9] |
Li Weiwei, Li Yanan.
Left atrial volume index predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis
[J]. Clinical Focus, 2022, 37(11): 965-968.
|
| [10] |
An Jingjing, Wang Xiaojuan, Deng Aiyun.
Radiofrequency ablation in treating pre-excited atrial fibrillation recurrence: A meta analysis
[J]. Clinical Focus, 2022, 37(10): 899-904.
|
| [11] |
Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang.
Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation
[J]. Clinical Focus, 2021, 36(5): 412-415.
|
| [12] |
Wang Yajie, Lin Wenhua, Jing Rui, Liu Jingjing, Lu Yujie.
Relationship between aVR lead ST-segment elevation with SYNTAX score in patients with acute non-ST-segment elevation myocardial infarction
[J]. Clinical Focus, 2021, 36(10): 933-936.
|
| [13] |
Geng Yanping, Wang Lili, Gu Jian, Qi Peng, Chen Shuxia.
Validity and reliability analysis of Chinese version of AntiClot Treatment Scale
[J]. Clinical Focus, 2020, 35(9): 788-791.
|
| [14] |
Sun Wei.
Prediction of no reflow phenomenon in patients with acute myocardial infarction undergoing coronary intervention by CHA2DS2VASc score
[J]. Clinical Focus, 2020, 35(9): 792-795.
|
| [15] |
Ma Jincai, Ma Rongzhi, Ma Zhenzhen.
Efficacy and safety of rivaroxaban in elderly patients with nonvalvular atrial fibrillation complicated with cardiac insufficiency
[J]. Clinical Focus, 2020, 35(5): 413-416.
|
